JNJ — Recent News Coverage
All news mentioning JNJ in ESEN's AI-graded feed
News stories with JNJ as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on JNJ. See /coverage/JNJ for the 30-day aggregate.
ZACKS.COM
·
2026-06-18
LOW
BEARISH
CORR-0.35
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) declined 2.48% to $228.39 while the broader market advanced, signaling relative weakness in the diversified healthcare giant despite positive equity sentiment. This divergence suggests sector-spe…
ZACKS.COM
·
2026-06-18
NEUTRAL
NEUTRAL
CORR0.15
Top Research Reports for Alphabet, Broadcom & Johnson & Johnson
$GOOGL
$AVGO
$JNJ
◈ ESEN AI
This article functions primarily as a research aggregation digest highlighting analyst coverage updates across 16 major equities, with particular emphasis on Alphabet (GOOGL), Broadcom (AVGO), and Johnson & Johnson (JNJ…
MANILATIMES.NET
·
2026-06-18
LOW
NEUTRAL
CORR0.15
Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape
$JNJ
◈ ESEN AI
This article reports on a DelveInsight clinical trial analysis covering the age-related macular degeneration (AMD) therapeutic landscape, highlighting 100+ pipeline drugs and 90+ development players. The focus is on res…
INVESTING.COM
·
2026-06-18
NEUTRAL
BULLISH
CORR0.58
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound
$LLY
$HUM
$DXCM
$JNJ
◈ ESEN AI
Eli Lilly (LLY), Humana (HUM), and DexCom (DXCM) are emerging as key drivers of a healthcare sector rebound, signaling renewed investor confidence in pharmaceutical innovation, managed care platforms, and continuous glu…
DAILYHODL.COM
·
2026-06-18
LOW
NEUTRAL
CORR0.15
Eldora Opens 280+ Tokenized US Stocks to 85+ Countries, Launches $20,000 Campaign
$JNJ
◈ ESEN AI
Eldora's expansion of tokenized US equities to 85+ countries represents a modest infrastructure development in digital asset distribution rather than a catalyst for institutional equity markets. The opening of 280+ toke…
MANILATIMES.NET
·
2026-06-18
LOW
NEUTRAL
CORR0.15
CME Outfitters Receives Gold Award at the 2026 Spring Digital Health Awards®
$JNJ
◈ ESEN AI
CME Outfitters secured a Gold Award at the 2026 Spring Digital Health Awards for its CaseWise™ platform, a patient-informed resource designed to support personalized care in inflammatory bowel disease (IBD). This recogn…
CNBC.COM
·
2026-06-17
NEUTRAL
NEUTRAL
CORR0.45
Here’s our monthly update on all 35 portfolio stocks, including Cramer's favorite name to buy
$JNJ
◈ ESEN AI
This monthly portfolio review from the Investing Club covers 35 holdings with curated commentary from Jim Cramer and Jeff Marks. The breadth across the portfolio—spanning multiple sectors and cap sizes—suggests a divers…
SEEKINGALPHA.COM
·
2026-06-17
NEUTRAL
NEUTRAL
CORR0.35
J&J avoiding GLP-1 space to focus on cancer drugs (JNJ:NYSE)
$JNJ
◈ ESEN AI
Johnson & Johnson has signaled a deliberate strategic pivot away from the high-growth GLP-1 drug category, where competitors like Novo Nordisk and Eli Lilly are capturing significant market share. This decision reflects…
FINANCE.YAHOO.COM
·
2026-06-16
NEUTRAL
BULLISH
CORR0.52
J&J CEO says curing certain cancers within a decade is realistic
$JNJ
◈ ESEN AI
J&J leadership has signaled ambitious R&D momentum by positioning the company for near-term cancer treatment breakthroughs within a decade. CEO Joaquin Duato's commentary reflects confidence in pipeline maturation and t…
FOXBUSINESS.COM
·
2026-06-16
HIGH
BULLISH
CORR0.72
Johnson & Johnson CEO credits Trump tax policy for $55B US investment push, including $1B in Florida
$JNJ
◈ ESEN AI
Johnson & Johnson announced a $55 billion domestic investment commitment, with leadership attributing the decision partly to the incoming Trump administration's tax and regulatory framework. This represents a significan…
FINANCE.YAHOO.COM
·
2026-06-16
LOW
NEUTRAL
CORR0.42
FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026?
$FHLC
$IYH
$JNJ
$ABBV
◈ ESEN AI
This comparative analysis examines two healthcare-focused ETFs—FHLC and IYH—highlighting how structural differences in portfolio construction and asset base influence their respective risk-return profiles. The distincti…
CNBC
·
2026-06-15
NEUTRAL
BULLISH
CORR0.62
Salesforce looks to strengthen its AI platform — plus, a positive note for J&J
$CRM
$JNJ
◈ ESEN AI
Salesforce's strategic emphasis on strengthening its AI platform signals competitive positioning within the enterprise software landscape, where generative AI adoption has become a key differentiator. This reflects broa…
FINANCE.YAHOO.COM
·
2026-06-15
NEUTRAL
BULLISH
CORR0.58
Factbox-Global drugmakers invest billions to boost US presence
$JNJ
◈ ESEN AI
Global pharmaceutical manufacturers are committing substantial capital to expand their operational footprint across the United States, signaling confidence in domestic market demand and regulatory environment. This inve…
FINANCE.YAHOO.COM
·
2026-06-14
LOW
BULLISH
CORR0.55
Jim Cramer Explains Johnson & Johnson’s (JNJ) Shares Have Gained
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) has demonstrated significant outperformance over recent periods, with year-to-date gains of 15% and a 53% increase over the trailing twelve months. This sustained appreciation reflects investor c…
FINANCE.YAHOO.COM
·
2026-06-14
LOW
NEUTRAL
CORR0.15
How to Build $3,000 a Month in Dividend Income Before You Turn 50
$JNJ
◈ ESEN AI
This article presents a personal finance educational piece focused on dividend income strategy rather than market-moving news. The content discusses methodology for building passive income through dividend-yielding secu…
MANILATIMES.NET
·
2026-06-14
HIGH
BULLISH
CORR0.72
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
$LEGN
$JNJ
◈ ESEN AI
Legend Biotech announced Phase 1 clinical proof-of-concept for LB2501, an in vivo dual-targeting CAR-T therapy designed to treat relapsed/refractory B-cell non-Hodgkin lymphoma. The milestone represents a significant va…
MANILATIMES.NET
·
2026-06-13
HIGH
BULLISH
CORR0.72
New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma
$JNJ
◈ ESEN AI
Johnson & Johnson's TALVEY® bispecific antibody combination has demonstrated clinically meaningful efficacy in the MonumenTAL-3 Phase 3 trial, with progression-free survival reaching 81.3% and overall survival at 89.2% …
INSIDERMONKEY.COM
·
2026-06-13
HIGH
BULLISH
CORR0.72
Johnson & Johnson (JNJ) to Acquire Firefly Bio for $1B
$JNJ
◈ ESEN AI
Johnson & Johnson's $1 billion acquisition of Firefly Bio represents a strategic inorganic growth play in the biotech space, signaling management confidence in expanding its therapeutic pipeline beyond core oncology and…
FINANCE.YAHOO.COM
·
2026-06-12
NEUTRAL
BULLISH
CORR0.35
Jim Cramer Says He Likes Drug Stocks Here As He Discusses Johnson & Johnson
$JNJ
◈ ESEN AI
Jim Cramer has signaled renewed confidence in pharmaceutical equities, using Johnson & Johnson (JNJ) as a case study for the sector's current appeal. His commentary reflects a tactical rotation away from technology lead…
INSIDERMONKEY.COM
·
2026-06-12
NEUTRAL
BULLISH
CORR0.35
Jim Cramer Says He Likes Drug Stocks Here As He Discusses Johnson & Johnson
$JNJ
◈ ESEN AI
Jim Cramer's commentary positions pharmaceutical and healthcare equities as a more reliable leadership vector relative to technology stocks, which he characterizes as having lost structural credibility. This represents …
FINANCE.YAHOO.COM
·
2026-06-12
LOW
NEUTRAL
CORR0.45
Johnson & Johnson (JNJ) Jumped on Market Optimism
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) experienced modest upward momentum amid broader market sentiment, though the underlying catalyst remains tangential to company-specific fundamentals. The mention of a price advance appears tied t…
INSIDERMONKEY.COM
·
2026-06-11
LOW
BULLISH
CORR0.42
Is Johnson & Johnson (JNJ) A Good Stock To Buy Now?
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) is the subject of renewed bullish commentary from dividend-focused investment analysts. The article references a thesis highlighting potential upside for the healthcare conglomerate, suggesting f…
ETFTRENDS.COM
·
2026-06-11
LOW
NEUTRAL
CORR0.32
Inside ASD: The Story Behind the First Autism ETF
$LFST
$ABBV
$JNJ
◈ ESEN AI
Defiance has launched a specialized autism-focused ETF that integrates autism research and advocacy into its investment thesis, representing a niche thematic strategy within the broader health care sector. The product i…
INSIDERMONKEY.COM
·
2026-06-11
NEUTRAL
BULLISH
CORR0.58
7 Best Longevity Stocks to Buy Now
$AMGN
$JNJ
◈ ESEN AI
The longevity investment theme reflects structural demographic shifts toward aging populations and increased healthcare spending. Companies positioned in anti-aging biotechnology, geriatric care, and chronic disease man…
ETFTRENDS.COM
·
2026-06-11
NEUTRAL
BULLISH
CORR0.52
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
$JNJ
$XLV
$XBI
◈ ESEN AI
Healthcare ETFs are positioning themselves as diversified alternatives to technology-heavy portfolios, capturing exposure across pharmaceuticals, biotechnology, and emerging therapeutic categories. The article highlight…
EXPLORE OTHER FILTERS